MCHRI’s PCOS Network, led by Professor Helena Teede, is a finalist in the Engagement Australia 2023 Excellence Awards – Excellence in International Engagement for Partnership for Global Impact: An international multidisciplinary, evidence-based, consumer-centric Network for better health.
The Polycystic Ovary Syndrome (PCOS) Network has delivered unprecedented collaboration, successive NHMRC approved International Evidence-based Guidelines translation and shared research priorities and programs. Extensive international collaboration encompasses 39 societies, six continents and 100+ multidisciplinary and lived-experience experts, amplifying patient voices through-out and reaching 196 countries to transform approaches to PCOS diagnosis and management. Multilingual translation provides equitable access to cutting-edge, digital, cost-free resources for healthcare professionals and women. As a vanguard of innovation, inclusivity, and excellence the Network and outputs merit recognition for advancing care for the 12% of women affected by this neglected condition.
The awards identify and celebrate the most exciting engagement activities undertaken by universities that demonstrate far-reaching impact and innovation in the economy and community in Australia and New Zealand.
The awards judging panel has commented on the exceptional quality of the submissions received this year.
Winners of the annual Excellence Awards for Engagement will be announced at an industry event on Tuesday, November 21.